Chemokine receptor antagonists and methods of use therefor

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 221/16 (2006.01) A61K 31/451 (2006.01) A61K 31/4523 (2006.01) A61K 31/4525 (2006.01) A61K 31/4535 (2006.01) A61K 31/4545 (2006.01) A61K 31/5377 (2006.01) A61K 31/55 (2006.01) C07D 211/52 (2006.01) C07D 225/08 (2006.01) C07D 313/10 (2006.01) C07D 313/12 (2006.01) C07D 337/12 (2006.01) C07D 405/06 (2006.01) C07D 409/06 (2006.01) C07D 409/14 (2006.01) C07D 491/04 (2006.01) C07D 491/044 (2006.01) C07D 493/04 (2006.01) C07D 495/04 (2006.01)

Patent

CA 2318088

Disclosed are novel compounds and a method of treating a disease associated with aberrant leukocyte recruitment and/or activation. The method comprises administering to a subject in need an effective amount of a compound represented by structural formula (I) and physiologically acceptable salts thereof.

L'invention concerne de nouveaux composés et un procédé de traitement associés au recrutement et/ou à l'activation aberrants d'un leucocyte. Le procédé consiste à administrer à un sujet une quantité effective d'un composé de la formule structurale (I) et des sels physiologiquement acceptables dudit composé.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Chemokine receptor antagonists and methods of use therefor does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Chemokine receptor antagonists and methods of use therefor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Chemokine receptor antagonists and methods of use therefor will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1525812

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.